TOKYO (Reuters) – Japan’s Konica Minolta said on Thursday it was purchasing U.S.-based testing company Ambry Genetics in a deal valued at up to $1 billion.
Konica Minolta to buy Ambry Genetics, deal worth up to $1 billion
Jul 6, 2017 | Bad Credit Loans, Bank Lending, Business Lending, Business Loans, Capital, Economics, Finance, Non-Bank Loans, Working Capital